Christine Lomas-Francis
New York Blood Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christine Lomas-Francis.
Transfusion | 2005
Ghazala Hashmi; Tasmia Shariff; Michael Seul; Prabhakar Vissavajjhala; Kim Hue-Roye; Dalisay Charles-Pierre; Christine Lomas-Francis; Asok Chaudhuri; Marion E. Reid
BACKGROUND: Typing for blood group antigens is currently performed by hemagglutination. The necessary reagents are becoming costly and limited in availability, and the methods are labor‐intensive. The purpose of this study was to determine the feasibility of the use of large‐scale DNA analysis in a microarray as a substitute for blood group typing.
Transfusion | 2007
Ghazala Hashmi; Tasmia Shariff; Yi Zhang; Joan Cristobal; Chiu Chau; Michael Seul; Prabhakar Vissavajjhala; Christopher Baldwin; Kim Hue-Roye; Dalisay Charles-Pierre; Christine Lomas-Francis; Marion E. Reid
BACKGROUND: A “BeadChip” array permits reliable simultaneous DNA typing of single‐nucleotide polymorphisms for minor blood groups. A high‐throughput DNA analysis was studied as a routine method of phenotype prediction and software was developed to interpret and analyze the large volume of data points.
Vox Sanguinis | 2004
Geoff Daniels; A. Fletcher; George Garratty; Stephen Henry; J. Jørgensen; W. J. Judd; Cyril Levene; Christine Lomas-Francis; J. J. Moulds; Joann M. Moulds; M. Moulds; M. A. M. Overbeeke; Marion E. Reid; Ph. Rouger; Marion L. Scott; Pertti Sistonen; E. Smart; Yoshihiko Tani; Silvano Wendel; Teresa Zelinski
1 Bristol Institute for Transfusion Sciences, Bristol, UK 2 Growing your Knowledge, Spit Junction, NSW, Australia 3 American Red Cross Blood Services, Los Angeles-Orange Counties Region, Los Angeles, CA, USA 4 Biotechnology Research Centre, Auckland University of Technology, Auckland, New Zealand 5 Regional Blood Transfusion Center, Department of Clinical Immunology, University Hospital, Arhus N, Denmark 6 Department of Pathology, University Hospitals UH-2G332, Ann Arbor, Michigan, USA 7 Reference Laboratory for Immunohematology and Blood Groups, National Blood Services Centre, Tel Hashomer, Israel 8 New York Blood Center, New York, NY, USA 9 Ortho-Clinical Diagnostics, Raritan, NJ, USA 10 Drexel University College of Medicine, Philadelphia, PA, USA 11 Gamma Biologicals Inc (subsidiary of Immunocor Inc), Houston, TX, USA 12 Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, the Netherlands 13 Centre national de Reference pour les Groupes sanguines (CNTS), Paris, France 14 International Blood Group Reference Laboratory, Bristol, UK 15 Finnish Red Cross Blood Transfusion Service, Helsinki, Finland 16 South African National Blood Service, East Coast Region, Pinetown, South Africa 17 Osaka Red Cross Blood Center, Osaka, Japan 18 Blood Bank, Hospital Sirio-Libanes, Sao Paulo, Brazil 19 Rh Laboratory, University of Manitoba, Winnipeg, Manitoba, Canada
Vox Sanguinis | 1995
Geoff Daniels; D. J. Anstee; J.-P. Cartron; W. Dahr; J. Jørgensen; L. Kornstad; Cyril Levene; Christine Lomas-Francis; A. Lubenko; D. Mallory; J. J. Moulds; Y. Okubo; M. A. M. Overbeeke; Marion E. Reid; Ph. Rouger; S. Seidl; Pertti Sistonen; Silvano Wendel; G. Woodfield; Teresa Zelinski
Since the first human blood groups were discovered almost a century ago, many hundreds of new red cell antigens have been identified. Because of the extended time period over which these antigens were discovered, a variety of different terminologies has been introduced. In some cases single capital letters were used (A, B, M, K), in some superscripts distinguished allelic products (Fy’, Fyh), and in some a numerical notation was introduced (Fy3). Some antigens were given different names in different laboratories, based on alternative genetic theories (D and Rho). In 1980 the International Society of Blood Transfusion (ISBT) established a Working Party to devise a genetically based numerical terminology for red cell surface antigens. In 1990 the Working Party published a monograph describing a numerical terminology for 242 red cell antigens [I], and brief updatings followed in 1991 [2] and 1993 [3]. In the 6 years since the 1990 report many amendments to the classification have been necessary: 18 new antigens have been identified and 6 others declared obsolete due to lack of suitable reagents; four new systems have been created (all from existing collections); the Auberger antigens joined the Lutheran system; the Gregory antigens and Jo” joined the Dombrock system; the Wright antigens joined the Diego system. Furthermore, since, 1990, many of the blood group genes have been isolated: of the genes controlling the 23 systems, only four (PI, JK, SC, DO) remain to be cloned. The purpose of this monograph is to describe the ISBT terminology for red cell surface antigens and to tabulate the complete 1995 version of the classification. In addition, an alternative ‘popular’ terminology is suggested in an attempt to reduce the number of different names used in publications on red cell antigens. Much of the information provided in the 1990 monograph [l] is reiterated here so that referral back will not generally be required, but only references after 1990 are provided.
Vox Sanguinis | 2014
Jill R. Storry; Lilian Castilho; G. Daniels; Willy A. Flegel; George Garratty; M. De Haas; C. Hyland; Christine Lomas-Francis; Joann M. Moulds; Nuria Nogues; Martin L. Olsson; Joyce Poole; Marion E. Reid; Philippe Rouger; E. van der Schoot; M. Scott; Yoshihiko Tani; L.-C. Yu; Silvano Wendel; Connie M. Westhoff; Vered Yahalom; T. Zelinski
The International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology convened during the International congress in Cancun, July 2012. This report details the newly identified antigens in existing blood group systems and presents three new blood group systems.
Vox Sanguinis | 2003
Geoff Daniels; Willy A. Flegel; A. Fletcher; George Garratty; Cyril Levene; Christine Lomas-Francis; Joann M. Moulds; J. J. Moulds; Martin L. Olsson; M. A. M. Overbeeke; J. Poole; Marion E. Reid; P. Rouger; C. E. Van Der Schoot; Marion L. Scott; Pertti Sistonen; E. Smart; Jill R. Storry; Yoshihiko Tani; Lung-Chih Yu; Silvano Wendel; Connie M. Westhoff; T. Zelinski
The Committee met in Cape Town during the 2006 Inter-national Society of Blood Transfusion (ISBT) Congress (seeAppendix 1 for Committee members). Some changes to theclassification documented in Blood Group Terminology 2004[1] were agreed and are described below. The full updatedclassification can be found on the Blood Group Terminologywebsite at http://www.blood.co.uk/ibgrl. New antigens wereadded to the MNS, Kell, Scianna, Cromer, Indian, Knops,and JMH systems (Table 1). In line with convention, aminoacid positions are numbered with the translation-initiatingmethionine as 1, although the more traditional numberingfor glycophorin A, with number 1 representing the first aminoacid of the mature protein, is also provided.
Vox Sanguinis | 2009
Geoff Daniels; Lilian Castilho; Willy A. Flegel; A. Fletcher; George Garratty; Cyril Levene; Christine Lomas-Francis; Joann M. Moulds; J. J. Moulds; Martin L. Olsson; M. A. M. Overbeeke; J. Poole; Marion E. Reid; P. Rouger; E. van der Schoot; M. Scott; Pertti Sistonen; E. Smart; Jill R. Storry; Yoshihiko Tani; L.-C. Yu; Silvano Wendel; Connie M. Westhoff; Vered Yahalom; T. Zelinski
The committee met in Macao Special Administrative Region,China, during the 2008 International Society of Blood Trans-fusion (ISBT) Congress. Some changes to the classificationdocumented in Blood Group Terminology 2004 [1] and updatedin 2007 [2] were agreed and are described below. The fullupdated classification can be found on the blood groupterminology website at http://www.blood.co.uk/ibgrl. A newblood group system, the RHAG system, was established andnew antigens were added to the Rh, Kell, and Dombrocksystems (Table 1). A total of 308 antigens are now recognized,270 of which are clustered in 30 blood group systems.
Vox Sanguinis | 1999
Geoff Daniels; David J. Anstee; J.-P. Cartron; W. Dahr; George Garratty; Stephen Henry; J. Jørgensen; W. J. Judd; L. Kornstad; Cyril Levene; Christine Lomas-Francis; A. Lubenko; J. J. Moulds; Joann M. Moulds; M. Moulds; M. Overbeeke; Marion E. Reid; Ph. Rouger; M. Scott; S. Seidl; Pertti Sistonen; Yoshihiko Tani; Silvano Wendel; Teresa Zelinski
The Working Party met at Makuhari Messe, Japan on 31 March 1996. A few changes to the current classification, documented in Blood Group Terminology 1995 [1], were agreed and these are described below.
Transfusion | 2010
Connie M. Westhoff; Sunitha Vege; Trina Whorley; Kim Hue-Roye; Christine Lomas-Francis; Marion E. Reid
BACKGROUND: The partial D phenotype DIIIa was originally reported to be associated with 455A>C in Exon 3, 602C>G in Exon 4, and 667T>G in Exon 5. Other alleles with these changes were subsequently identified and designated DIII Types 5, 6, and 7, as they had additional alterations. The observation that DNA samples associated with the DIIIa phenotype had more changes than those originally reported motivated us to reanalyze the DIIIa probands (BP and DJ) from the original study. We also studied additional DIIIa samples to clarify the RHD background and establish the associated RHCE.
Vox Sanguinis | 2001
Geoff Daniels; D. J. Anstee; J.-P. Cartron; W. Dahr; A. Fletcher; George Garratty; Stephen Henry; J. Jørgensen; W. J. Judd; L. Kornstad; Cyril Levene; M. Lin; Christine Lomas-Francis; A. Lubenko; J. J. Moulds; Joann M. Moulds; M. Moulds; M. A. M. Overbeeke; Marion E. Reid; Philippe Rouger; Marion L. Scott; Pertti Sistonen; E. Smart; Yoshihiko Tani; Silvano Wendel; Teresa Zelinski
G. L. Daniels (Chair), D. J. Anstee, J. P. Cartron, W. Dahr, A. Fletcher, G. Garratty, S. Henry, J. Jorgensen, W. J. Judd, L. K ornstad, C. Levene, M. Lin, C. Lomas-Francis, A. Lubenko, J. J. Moulds, J. M. Moulds, M. Moulds, M. Overbeeke, M. E. Reid, P. Rouger, M. Scott, P. Sistonen, E. Smart, Y. Tani, S. Wendel & T. Zelinski*